More Globe Newswire

View Older Stories View Newer Stories

Nov 7, 2025 08:00AM MAX Power Begins Historic Drilling of Canada’s First-Ever Natural Hydrogen Well
Nov 7, 2025 08:00AM ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025
Nov 7, 2025 08:00AM Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
Nov 7, 2025 08:00AM Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Live
Nov 7, 2025 08:00AM Black Friday Starts Early at Curacao: Three Weeks of Massive Savings You Can’t Miss
Nov 7, 2025 08:00AM Vor Bio to Participate in Upcoming Investor Conferences
Nov 7, 2025 08:00AM Vaxart to Host Upcoming Conference Calls
Nov 7, 2025 08:00AM Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
Nov 7, 2025 08:00AM Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
Nov 7, 2025 08:00AM AirJoule Technologies Schedules Release of Third Quarter 2025 Results and Conference Call
Nov 7, 2025 08:00AM Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
Nov 7, 2025 08:00AM Dycom Industries, Inc. to Host Fiscal 2026 Third Quarter Results Conference Call
Nov 7, 2025 08:00AM Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
Nov 7, 2025 08:00AM Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
Nov 7, 2025 08:00AM Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Nov 7, 2025 08:00AM ESET to aid MSPs by integrating with ConnectWise Asio
Nov 7, 2025 08:00AM Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies
Nov 7, 2025 08:00AM Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA pri
Nov 7, 2025 08:00AM Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
Nov 7, 2025 07:45AM illumin Reports Third Quarter 2025 Financial Results
Nov 7, 2025 07:43AM Form 8.3 - Unite Group plc.
Nov 7, 2025 07:42AM Form 8.3 - Idox
Nov 7, 2025 07:41AM Form 8.3 - Empiric Student Property Plc
Nov 7, 2025 07:40AM Form 8.3 - Bluefield Solar Income Fund Ltd.
Nov 7, 2025 07:39AM Jackbit Sets New Benchmark for No ID Crypto Casinos
Nov 7, 2025 07:34AM AIS 5G Supports The 74th Miss Universe 2025 — Welcomes Global Contestants with Special SIM Packages
Nov 7, 2025 07:32AM Barrick Completes Sale of Alturas Project
Nov 7, 2025 07:30AM Tree Island Renews Normal Course Issuer Bid
Nov 7, 2025 07:30AM Copyseeker Pioneers Visual Search Integration in AI with Model Context Protocol Launch
Nov 7, 2025 07:30AM TERRA CLEAN PROVIDES CORPORATE UPDATE
Nov 7, 2025 07:30AM Almadex Announces Plans to Drill New Hope Porphyry Project, Arizona and Provides Paradise Drill Program Update
Nov 7, 2025 07:30AM Holley Reports Third Quarter 2025 Results
Nov 7, 2025 07:30AM Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 07:30AM Relmada Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 13, 2025
Nov 7, 2025 07:30AM Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 7, 2025 07:30AM Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
Nov 7, 2025 07:30AM Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
Nov 7, 2025 07:30AM Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
Nov 7, 2025 07:30AM Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
Nov 7, 2025 07:30AM BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
Nov 7, 2025 07:30AM Nexxen to Announce Third Quarter 2025 Financial Results on November 13, 2025
Nov 7, 2025 07:27AM Foremost Hat Launches 2025 Sustainable Beanie Collection for Brands and Retailers
Nov 7, 2025 07:18AM Notification of managers’ transactions
Nov 7, 2025 07:00AM Evergold Announces Closing of $350,000 Convertible Debenture Private Placement with CJ “Charlie” Greig; Drilling at DEM is Underway
Nov 7, 2025 07:00AM Onex Reports Third Quarter 2025 Results
Nov 7, 2025 07:00AM Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 07:00AM MADD Canada Unveils Roadside Memorial Sign in Trenton in Honour of Rebecca Beatty Killed in Impaired Driving Crash
Nov 7, 2025 07:00AM Boralex announces its third quarter results and commissioning of large-scale projects in Canada
Nov 7, 2025 07:00AM Lagoon Furniture at BDNY 2025 | Stylish & Durable Hospitality Design
Nov 7, 2025 07:00AM Brookfield Infrastructure Reports Strong Third Quarter 2025 Results
View Newer Stories View Older Stories